Publication details
Nestin expression in high
-grade osteosarcomas and its clinical significance
| Basic information | |
|---|---|
| Original title: | Nestin expression in high -grade osteosarcomas and its clinical significance |
| Authors: | Iva Zambo, Markéta Hermanová, Dagmar Adámková Krákorová, Peter Múdry, Karel Zitterbart, Michal Kýr, Karel Veselý, Jaroslav Štěrba, Renata Veselská |
| Further information | |
|---|---|
| Citation: | ZAMBO, Iva, Markéta HERMANOVÁ, Dagmar ADÁMKOVÁ KRÁKOROVÁ, Peter
MÚDRY, Karel ZITTERBART, Michal KÝR, Karel VESELÝ, Jaroslav
ŠTĚRBA and Renata VESELSKÁ. Nestin expression in high -grade
osteosarcomas and its clinical significance. Oncology Reports,
Athens, Greece: Spandidos Publications Ltd., 2012, vol. 27, No
5, p. 1592 -1598. ISSN 1021 -335X. doi:10.3892/or.2012.1687.Export BibTeX |
| Original language: | English |
| Field: | Oncology and hematology |
| Type: | Article in Periodical |
| Keywords: | osteosarcoma; nestin; prognosis; immunohistochemistry; immunofluorescence |
Using immunohistochemistry and immunofluorescence, we evaluated nestin expression in tumor tissue samples from 45 patients with high-grade osteosarcomas. High levels of nestin expression detected by immunofluorescence were associated with worse clinical outcomes. However, high levels of nestin expression detected by immunohistochemistry trended towards shorter OS and EFS but did not reach statistical significance. Nestin does not seem to represent a powerful prognostic marker for patients with high-grade osteosarcomas.
Related projects:











